J-ACCESS investigation and nuclear cardiology in Japan: implications for heart failure

Kenichi Nakajima1, Tsunehiko Nishimura2

  • 1Department of Functional Imaging and Artificial Intelligence, Kanazawa University, Kanazawa, 920-8640, Japan. nakajima@med.kanazawa-u.ac.jp.

Insights

Heart failure (HF) is rising in Japan, with severe HF events disproportionately affecting patients undergoing nuclear cardiology. Age, perfusion defects, and comorbidities like diabetes predict these cardiovascular events.

Area of Science:

  • Cardiology
  • Nuclear Cardiology
  • Public Health

Background:

  • Coronary heart disease is a global mortality cause, but heart failure (HF) prevalence is increasing in developed nations, notably Japan.
  • Japan's HF demographic features an aging population and lower incidence of ischemic origins.
  • Multicenter J-ACCESS investigations have provided extensive data on nuclear cardiology practice and prognosis over two decades in Japan.

Purpose of the Study:

  • To clarify the background and reasons for the high proportion of severe HF events in Japan.
  • To identify predictors of major adverse cardiac events in patients undergoing nuclear cardiology examinations.
  • To emphasize risk-based approaches for optimal medical therapy and coronary revascularization.

Main Methods:

  • Analysis of data from the multicenter prognostic J-ACCESS investigations (Series 1-4).
  • Identification of predictors for major adverse cardiac events and severe HF requiring hospitalization.
  • Review of clinical guidelines regarding non-invasive imaging for chronic coronary artery disease.

Main Results:

  • While hard cardiac events are less frequent in Japan than in the USA/Europe, similar predictors for major adverse cardiac events were identified.
  • Severe heart failure requiring hospitalization constituted the largest proportion (50-75%) of major events in J-ACCESS registries.
  • Age, myocardial perfusion defects, left ventricular dysfunction, diabetes, and chronic kidney disease are key predictors of cardiovascular events, including severe HF.

Conclusions:

  • The high incidence of severe HF events in Japan warrants further investigation into underlying factors.
  • Risk stratification incorporating age, cardiac function, perfusion defects, and comorbidities is crucial for managing cardiovascular events.
  • Updated clinical guidelines highlight the importance of non-invasive imaging and risk-based strategies for chronic coronary artery disease management.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
15
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
39
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
19
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
28
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
224
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
18